Peritoneal Tumour DNA in Peritoneal Fluid: Emerging Tool for Peritoneal Metastasis Detection.

Cytology Gastrointestinal cancer Peritoneal metastases Peritoneal tumour DNA

Journal

Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627

Informations de publication

Date de publication:
29 May 2024
Historique:
accepted: 18 05 2024
medline: 29 5 2024
pubmed: 29 5 2024
entrez: 29 5 2024
Statut: aheadofprint

Résumé

The prognostic significance of positive peritoneal cytology still varied between cancer types and geographical origin. However, because of the lack of sensitivity of this biomarker, conventional cytology is not routinely performed in every country. Here, we wanted to test a new biomarker, peritoneal tumour DNA, using NGS technique, in order to compare it with the historical one, in patients having peritoneal metastases of gastrointestinal or ovarian cancer.

Identifiants

DOI: 10.1007/s12029-024-01071-1 PMID: 38809368
pubmed: 38809368
doi: 10.1007/s12029-024-01071-1
pii: 10.1007/s12029-024-01071-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Cotte E, Peyrat P, Piaton E, Chapuis F, Rivoire M, Glehen O, et al. Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study. Eur J Surg Oncol. 2013;39:707–14.
doi: 10.1016/j.ejso.2013.03.021 pubmed: 23601984
Bachet JB, Laurent-Puig P, Meurisse A, Bouché O, Mas L, Taly V. Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study. Eur J Cancer. 2023;189:112934.
doi: 10.1016/j.ejca.2023.05.022 pubmed: 37390800
Cohen R, Platell CF, McCoy MJ, Meehan K, Fuller K. Circulating tumour DNA in colorectal cancer management. Br J Surg. 2023;znad126.
Pécuchet N, Rozenholc Y, Zonta E, Pietrasz D, Didelot A, Combe P, et al. Analysis of base-position error rate of next-generation sequencing to detect tumor mutations in circulating DNA. Clin Chem. 2016;62:1492–503.
doi: 10.1373/clinchem.2016.258236 pubmed: 27624137
Van’t Erve I, Rovers KP, Constantinides A, Bolhuis K, Wassenaar EC, Lurvink RJ, et al. Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid. J Pathol Clin Res. 2021;7:203–8.
doi: 10.1002/cjp2.207 pubmed: 33635598 pmcid: 8073000
Sullivan BG, Lo A, Yu J, Gonda A, Dehkordi-Vakil F, Dayyani F, et al. Circulating tumor DNA is unreliable to detect somatic gene alterations in gastrointestinal peritoneal carcinomatosis. Ann Surg Oncol. 2023;30:278–84.
doi: 10.1245/s10434-022-12399-y pubmed: 35980549

Auteurs

Antoine Mariani (A)

Department of Digestive Surgery, Université Paris Cité, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Paris, France. antoine.mariani@aphp.fr.

Hélène Blons (H)

Pharmacogenomics and Molecular Oncology Unit, Biochemistry Department, Université Paris Cité, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Paris, France.

Henri Azais (H)

Department of Gynecologic Surgery, Université Paris Cité, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Paris, France.

Pierre Laurent-Puig (P)

Department of Biology, INSERM-UMR-S1147, Université Paris Cité, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Paris, France.

Aziz Zaanan (A)

Department of Digestive Oncology, Université Paris Cité, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Paris, France.

Amira Gharbi (A)

Pharmacogenomics and Molecular Oncology Unit, Biochemistry Department, Université Paris Cité, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Paris, France.

Classifications MeSH